Premium
Evidenced‐based clinical practice guideline for upper tract urothelial carcinoma (summary – J apanese U rological A ssociation, 2014 edition)
Author(s) -
Oya Mototsugu,
Kikuchi Eiji
Publication year - 2015
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/iju.12630
Subject(s) - medicine , guideline , urothelial carcinoma , urothelial cancer , clinical practice , bladder cancer , carcinoma , incidence (geometry) , cancer , chemotherapy , oncology , urology , family medicine , pathology , physics , optics
Upper tract urothelial carcinoma is more rare than bladder cancer, although they are both categorized as urothelial carcinoma. Because of the low incidence, little clinical evidence is available regarding the treatment of the former. However, recently such evidence has slowly begun to accumulate. The guideline presented herein was compiled for the purpose of ensuring proper diagnosis and treatment by physicians involved in the treatment of upper tract urothelial carcinoma. We carefully selected 16 clinical questions essential for daily clinical practice and grouped them into four major categories: epidemiology, diagnosis, surgery and systemic chemotherapy/other matters. Related literature was searched using P ub M ed and J apan M edical A bstracts S ociety databases for articles published between 1987 and 2013. If the judgment was made on the basis of insufficient or inadequate evidence, the grade of recommendation was determined on the basis of committee discussions and resultant consensus statements. Here, we present a short E nglish version of the original guideline, and overview its key clinical issues.